Deliver Biosciences Limited
Research and experimental development on biotechnology · Truro
ActiveUnited KingdomIncorporated 2019Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 102 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 102 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 49
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2604_12074975_20250630
- Source archive
- Accounts_Monthly_Data-April2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 98 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2024-06-30
IXBRL · 98 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-07-01 to 2024-06-30
- Extraction status
- complete
- Numeric facts
- 44
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2503_12074975_20240630
- Source archive
- Accounts_Monthly_Data-March2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2022-06-30
IXBRL · 78 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2022-06-30
IXBRL · 78 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2021-07-01 to 2022-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 34
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0009_12074975_20220630
- Source archive
- Accounts_Monthly_Data-March2023.zip
Accounts to 2021-06-30
IXBRL · 96 source facts · 17 selected values
Not assessedlegacy record
Accounts to 2021-06-30
IXBRL · 96 source facts · 17 selected values
Not assessed
legacy record
- Reporting period
- 2020-07-01 to 2021-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 51
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0105_12074975_20210630
- Source archive
- Accounts_Monthly_Data-April2022.zip
Accounts to 2020-06-30
IXBRL · 58 source facts · 7 selected values
Not assessedlegacy record
Accounts to 2020-06-30
IXBRL · 58 source facts · 7 selected values
Not assessed
legacy record
- Reporting period
- 2019-06-28 to 2020-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 14
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0091_12074975_20200630
- Source archive
- Accounts_Monthly_Data-June2021.zip
Registered details
12074975- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2019-06-28
- Jurisdiction
- —
- Registered office
- GARLENICK, GRAMPOUND, TRURO, CORNWALL, TR2 4RE, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsBuilding a VAST platform to rapidly engineer novel synthetic gene delivery vectorsLead
Innovate UK · Collaborative R&D · 2024-02-01 – 2025-01-31
£336,547
awarded
Democratisation of cell and gene therapies using NanoCAR technologyLead
Innovate UK · Grant for R&D · 2023-04-01 – 2024-03-31
£50,000
awarded
Development of an in-body cell therapy treatment using nanoparticlesLeadInnovate UK · Collaborative R&D · 2022-06-01 – 2024-03-31 · with 2 other participants£278,860awarded
Development of an in-body cell therapy treatment using nanoparticlesLead
Innovate UK · Collaborative R&D · 2022-06-01 – 2024-03-31 · with 2 other participants
£278,860
awarded
Deliver Biosciences Limitedlead£278,860